Home TIDES Weekly: Oral Semaglutide EMA Recommendation & Multiple Oligonucleotide Therapies Show Positive Progress in Hepatitis B

TIDES Weekly: Oral Semaglutide EMA Recommendation & Multiple Oligonucleotide Therapies Show Positive Progress in Hepatitis B

May 31, 2026 07:30 CST Updated 09:55
GSK

Pharmaceutical R&D Manufacturer

Ionis Pharmaceuticals

RNA Drug Developer